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http://dxObjective: Continuous glucose monitoring could be helpful for glucose regulation in critically ill patients;
however, its accuracy is uncertain and might be influenced by microcirculation. We investigated the micro-
circulation and its relation to the accuracy of 2 continuous glucose monitoring devices in patients after cardiac
surgery.
Methods: The present prospective, observational study included 60 patients admitted for cardiac surgery.
Two continuous glucose monitoring devices (Guardian Real-Time and FreeStyle Navigator) were placed before
surgery. The relative absolute deviation between continuous glucose monitoring and the arterial reference
glucose was calculated to assess the accuracy. Microcirculation was measured using the microvascular flow
index, perfused vessel density, and proportion of perfused vessels using sublingual sidestream dark-field
imaging, and tissue oxygenation using near-infrared spectroscopy. The associations were assessed using a linear
mixed-effects model for repeated measures.
Results: The median relative absolute deviation of the Navigator was 11% (interquartile range, 8%-16%) and
of the Guardian was 14% (interquartile range, 11%-18%; P¼ .05). Tissue oxygenation significantly increased
during the intensive care unit admission (maximum 91.2% [3.9] after 6 hours) and decreased thereafter,
stabilizing after 20 hours. A decrease in perfused vessel density accompanied the increase in tissue oxygenation.
Microcirculatory variables were not associated with sensor accuracy. A lower peripheral temperature
(Navigator, b¼0.008, P¼ .003; Guardian, b¼0.006, P¼ .048), and for the Navigator, also a higher Acute
Physiology and Chronic Health Evaluation IV predicted mortality (b ¼ 0.017, P<.001) and age (b ¼ 0.002,
P ¼ .037) were associated with decreased sensor accuracy.
Conclusions: The results of the present study have shown acceptable accuracy for both sensors in patients after
cardiac surgery. The microcirculation was impaired to a limited extent compared with that in patients with sepsis
and healthy controls. This impairment was not related to sensor accuracy but the peripheral temperature for both
sensors and patient age and Acute Physiology and Chronic Health Evaluation IV predicted mortality for the
Navigator were. (J Thorac Cardiovasc Surg 2013;146:1283-9)Intensive glucose control is widely practiced in the
intensive care unit (ICU). However, the associated frequent
glucose measurements are time consuming, and no infor-
mation is available about the glucose values between those
measurements. The occurrence of hypoglycemia has been
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Mrespiratory complications and prolonged hospital and ICU
lengths of stay after cardiac surgery.1 Continuous glucose
monitoring (CGM) could be a step forward by decreasing
severe hypoglycemia frequency2 and increasing the time
within the blood glucose target range. Although we recently
reported promising results for continuous glucose sensor
accuracy in cardiac surgery patients,3 a patient population
that seems to benefit from intensive insulin treatment,4
other studies have reported suboptimal accuracy with the
commercially available systems.5,6
A part of the accuracy problem in critically ill patients
could have been because the current commercially available
needle-type continuous glucose sensors measure the
glucose concentrations in the interstitial fluid and not
directly in the blood. The transport of molecules such as
glucose to the interstitial fluid is dependent on the glucose
supply to the tissue and, therefore, on microcirculatory
function, although the exact interstitial glucose kinetics in
response to vascular changes are unknown. In critically ill
patients, the microcirculatory function has been altered,7,8




¼ Acute Physiology and Chronic Health
Evaluation IV predicted mortality
CGM ¼ continuous glucose monitoring
HI ¼ heterogeneity index
ICU ¼ intensive care unit
IQR ¼ interquartile range
MFI ¼ microvascular flow index
PVD ¼ perfused vessel density
PPV ¼ proportion of perfused vessels
RAD ¼ relative absolute deviation
SDF ¼ sidestream dark-field
StO2 ¼ tissue oxygenation
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MIn the present investigator-initiated study, we investi-
gated the microcirculation in patients after cardiac surgery
in the ICU and assessed whether microcirculatory variables
and other patient-related factors were associated with
the accuracy of the Guardian Real-Time (Medtronic
Minimed, Northridge, Calif) and FreeStyle Navigator
(Abbott Diabetes Care, Alameda, Calif) continuous glucose
monitoring systems.METHODS
Patients
We performed a prospective observational study in a 20-bed mixed ICU
in the Onze Lieve Vrouwe Gasthuis (Amsterdam, The Netherlands). The
institutional review board approved the study. We included patients aged
>18 years who were to undergo elective cardiac surgery: coronary artery
bypass grafting and/or valve surgery. We excluded patients with an
abdominal condition that would impair sensor insertion. The eligible
patients received an information letter 1 week before admission and
were asked to give written informed consent after additional explanation
of the study the day before surgery.
Glucose Monitoring
We used 2 needle-type sensors (Guardian Real-Time, Medtronic
Minimed, and FreeStyle Navigator, Abbott Diabetes Care). These sensors
quantify the interstitial glucose concentrations by way of the glucose
oxidation reaction, with the enzyme immobilized on a subcutaneously
inserted electrode. After we obtained informed consent, the sensors were
inserted in the abdominal wall on either side of the umbilicus the day before
surgery and were calibrated to allow stabilization of the signal. On arrival at
the ICU after surgery, the device’s internal clock was synchronized with
the bedside computer, and both devices were calibrated simultaneously.
Additional calibrations were performed according to the manufacturers’
instructions. The devices were removed after 48 hours of ICU admission
or earlier, when the patient was discharged.
A reference arterial blood glucose value was measured using the
AccuChek handheld glucose measurement device (Performa II, lot
320098; Roche/Hitachi, Basel, Switzerland) every 2 hours. These samples
were used as calibration when needed and as reference otherwise. An
in-house quality assurance study showed that the slope of the regression
between this point-of-care measurement method and arterial glucose
measurement by blood gas analysis was 1.0 (95% confidence interval
1.00-1.02, n ¼ 1393, sample range 2.9-30.0 mmol/L; Passing-Bablok
regression), and 95% of the absolute differences between the reference1284 The Journal of Thoracic and Cardiovascular Surand point-of-care measurements were lower than 15%, meeting the Interna-
tional Organization for Standardization protocol number 15197 guideline.
The results were stored in the ICU’s clinical information system (iMD-
Soft;MetaVision,TelAviv, Israel).Using a dynamiccomputerizedalgorithm
implemented in 2001,9 glucose values of 5.0 to 8.0 mmol/L were targeted.
The nursing staff adjusted the insulin infusion rate according to the current
arterial glucose value and the rate of glucose change determined from the
previous 5 measurements and did not act on the sensor glucose values.
To assess the real-time accuracy of the devices, we calculated the
relative absolute deviation (RAD) (jsensor value  reference glucosej/
reference glucose) between the reference glucose and sensor glucose
values. For this purpose, we linked the reference value to the first available
sensor value within 5 minutes after the reference value had been measured.Microcirculation Measurement
We assessed the microcirculation sublingually, after removal of excess
saliva, using a handheld sidestream dark-field (SDF) camera. This method
has been previously described10 and is representative of the microcircula-
tion of other vascular beds.11 Imaging was performed as soon as the patient
arrived at the ICU, 2 and 4 hours thereafter, and at 8 AM, 12 PM, and 16 PM
on the subsequent days until the patient was discharged from the ICU or at
48 hours after ICU admission, whichever came first. At each point, SDF
recordings of 3 different sublingual sites were recorded, stored, and
scored in random order to prevent bias. The recordings were excluded
when no flow was visible in the large vessels, indicating a pressure artifact,
the presence of excess saliva making it impossible to reliably visualize all
vessels, and/or excess movement. We analyzed vessels with a diameter of
<20 mm, in line with previous data,12 because these capillaries and small
venules are considered to be the most important in nutrient (ie, glucose)
transport. Together with every SDF recording, a reference plasma glucose
measurement was obtained to calculate sensor accuracy.
We scored the microvascular flow index (MFI), proportion of perfused
vessels (PPV), and perfused vessel density (PVD) per sublingual site per
patient. The 3 outcomes per measurement point per patient were then
averaged according to the consensus statement on how to evaluate the
microcirculation13 using the automated vascular analysis program, version
3.0 (Department of Medical Technological Development, Academic
Medical Center, and MicroVision Medical, Amsterdam, The Netherlands).
In brief, for the PVD and PPV, the vessel density was calculated as the
number of vessels crossing 3 horizontal and 3 vertical equidistant lines
divided by the total length of the lines. The perfusion of the crossing vessels
was scored as follows: 0, no flow; 1, intermittent flow (flow present<50%
of the recording); 2, sluggish flow (flow present>50% but<100% of the
recording or continuous very slow flow); and 3, continuous flow. PVD was
calculated as the number of crossing vessels with flow present (score 2 or 3)
reported in n/mm. The PPV is the proportion of vessels with flow present
(score 2 or 3).7 For the MFI, the predominant type of flow in 4 quadrants
was determined according to the same scoring system. The MFI is the
sum of these flow scores divided by the number of quadrants in which
the vessel type is visible.14 The heterogeneity index (HI) per measurement
point for the PVD was calculated by dividing the difference between the
lowest and highest value by the mean to objectify the intrasite differences
per measurement point.15
The MFI was scored by 2 of us (S.E.S. and T.B.) and was compared and
revised by consensus when the separate scores differed by>1 point. The
final score was obtained by averaging the separate scores. The separate
scores never differed>1 point. The mean intraobserver difference was
0.06 points (range, 0.00-0.31) on the 3-point MFI scale. The points did
not differ at all between the 2 investigators 40% of the time. The PPV
and PVD were scored by 1 of us (S.E.S.), and the intraobserver variability
was determined by reanalyzing 17 randomly chosen movie sequences
after 4 weeks. The intraclass correlation coefficient was calculated using
a 2-way random model to determine the absolute agreement. The intra-
class correlation coefficient for PVD was 0.94 (95% confidence interval,gery c November 2013
TABLE 1. Patient characteristics (n ¼ 60)
Characteristic Value
Male gender (n) 48 (80.0)
Age (y) 65.0 (59.0-73.8)
Diabetes (n) 16 (26.7)
Procedure (n)
CABG 32 (53.3)
Valve surgery 16 (26.7)
CABG plus valve surgery 12 (20.0)
APACHE IV PM 0.01 (0.003-0.02)
Maximal SOFA score 6.0 (5.3-7.0)
EuroSCORE 4.0 (2.0-5.0)
ICU stay (h) 23.0 (19.0-45.8)
ICU readmission (n) 6 (10.0)
Death in ICU or hospital (n) 0
Glucose ICU 8.2  2.1
RAD Navigator (%) 11 (8-15)
RAD Guardian (%) 14 (11-18)
Dopamine (mg/kg/min) (n ¼ 60) 1.62 (1.03-2.34)
Nitroglycerine (mg/kg/min) (n ¼ 57) 0.22 (0.16-0.34)
Enoximon (mg/kg/min) (n ¼ 40) 1.19 (0.80-1.71)
Ketanserine (mg/kg/min) (n ¼ 4) 0.26 (0.08-0.39)
Noradrenaline (mg/kg/min) (n ¼ 1) 0.09
MFI small vessels 2.8 (2.7-2.9)
PPV small vessels 0.97 (0.96-0.99)
PVD small vessels (n/mm) 9.3 (8.4-10.0)
Heterogeneity index PVD 0.17 (0.13-0.21)
StO2 (%) 90.3 (87.1-92.0)
SpO2 (%) 97.2 (95.7-98.6)
Rectal temperature (C) 36.8 (36.4-37.1)
Peripheral temperature (C) 32.8 (31.6-33.6)
HF (beats/min) 84.2 (74.4-90.0)
MAP (mm Hg) 73.6 (69.3-81.0)
Hemoglobin (mmol/L) 5.8 (5.6-6.4)
Hematocrit (L/L) 0.29 (0.28-0.31)
Data are presented as median (IQR), n (%), or mean standard deviation, calculated
from the mean per patient during ICU admission. Valve surgery includes mitral valve
plasty, tricuspid valve plasty, aortic valve replacement or a combination of these.
CABG, Coronary artery bypass grafting; APACHE IV PM, Acute Physiology and
Chronic Health Evaluation IV predicted mortality; SOFA, sequential organ failure
assessment score per patient during the study period; EuroSCORE, European system
for cardiac operative risk evaluation; ICU, intensive care unit; RAD, relative absolute
deviation; MFI, microvascular flow index; PPV, proportion of perfused vessels;
PVD, perfused vessel density; SpO2, peripheral oxygenation; StO2, tissue oxygena-
tion; HF, heart frequency; MAP, mean arterial pressure.
Siegelaar et al Perioperative Management0.84-0.98) and for PPV was 0.94 (95% confidence interval, 0.84-0.98),
indicating good intraobserver agreement.
The tissue oxygenation (StO2) was measured using near-infrared
spectroscopy to assess the microcirculatory function (InSpectra StO2
Tissue Oxygenation Monitor; Hutchinson Technology, Hutchinson,
Minn). The StO2 is a measure of oxygen consumption of the tissue and a
predictor of organ dysfunction.16 It reflects the ratio of oxygenated
hemoglobin to total hemoglobin in the microcirculation measured by the
absorption of near infrared light (wavelength, 700-1000 nm). The probe
was placed on the thenar muscle at ICU arrival and removed after 48 hours
or on discharge from the ICU.
Other Variables
Other factors possibly influencing CGM accuracy were also obtained at
every reference glucose measurement: mean arterial pressure, peripheral
skin temperature, rectal temperature, pulse oximeter oxygen saturation,
and dosing of vasoactive medication. The Acute Physiology and Chronic
Health Evaluation IV predicted mortality (APACHE IV PM) was
calculated for the first 24 hours of admission, and the Sequential Organ
Failure score was obtained daily. Also, the European system for cardiac
operative risk evaluation score, a method of calculating the predicted
operative mortality risk of patients undergoing cardiac surgery, was
recorded for every patient.
Data Interpretation and Statistical Analysis
The median and interquartile range (IQR) RAD per patient was
calculated for each sensor, and both sensors were compared using a
Wilcoxon signed ranks test for non-normally distributed paired data. For
each sensor, all paired samples of the reference glucose values and
matching next sensor values were plotted in a Clarke error grid,17 which
is divided into 5 zones. Zones A and B represent values that are clinically
acceptable. Zone A represents values that differed 20% from the
reference value. Zone B represents values that differed>20% but would
not lead to a different treatment decision. Zone C represents values that
would result in overcorrecting acceptable glucose values. Zone D repre-
sents values that are erroneously not corrected, and zone E represents
values that would result in the opposite treatment (eg, glucose-lowering
therapy in reaction to a hypoglycemic value). To describe the patient
characteristics and overall circulatory function, the median and IQR or
mean  standard deviation per patient were calculated (Tables 1 and 2).
The associations between sensor accuracy and individual circulatory
variables were assessed using a linear mixed-effects model for repeated
measures. Second, we built a multivariate model for each sensor that
included those variables with a significant association with the accuracy
of that specific sensor. Finally, the microcirculatory variables (MFI,
PVD, PPV, and StO2) were forced in turn into the definite model to assess
the possible independent effect on sensor accuracy. All analyses were
performed using Predictive Analytics Software (PASW) statistics, version
18.0 (SPSS Inc, Chicago, Ill). P < .05 was considered statistically
significant. The European Foundation for the Study of Diabetes/LifeScan
did not have any role in the interpretation of the data.P
MRESULTS
We included 61 patients in the present study, of whom,
1 patient withdrew owing to cancellation of surgery because
of febrile illness. Thus, 60 patients were available for the
final analysis (48 men). The median age was 65 years
(range, 25-85), and 16 patients had previously been
diagnosed with type 2 diabetes. Most patients underwent
only coronary artery bypass grafting (n ¼ 32). The median
European system for cardiac operative risk evaluation scoreThe Journal of Thoracic and Carwas 4.0 (IQR, 2.0-5.0). The median APACHE IV PM and
maximum Sequential Organ Failure score was 0.01
(IQR, 0.003-0.02) and 6.0 (IQR, 5.3-7.0), respectively.
The patient characteristics are listed in Table 1.Microcirculation
SDF recordings at 246 measurement points met our
quality criteria for the MFI assessment, with a median of 4
points per patient (IQR, 3-5). For the PVD and PPV scoring,
only 178 points were suitable because of excessive move-
ment of 1 of the 3 recordings of that point (median, 3 per
patient; IQR, 2-4). The median MFI, PVD, PPV, HI PVD,diovascular Surgery c Volume 146, Number 5 1285
TABLE 2. Covariates associated with sensor accuracy
Variable
Univariate Multivariate
b SE P value b SE P value AIC
Navigator 1085.935
APACHE IV PM 0.017 0.010 <.001 0.017 0.004 <.001
Age 0.002 0.001 <.001 0.002 0.001 .037
Peripheral temperature 0.009 0.003 .001 0.008 0.003 .003
Dopamine dose 0.008 0.003 .006 0.001 0.004 .785
Enoximon dose 0.016 0.006 .008 0.009 0.007 .207
DM (no vs yes) 0.038 0.016 .019 0.024 0.018 .177
Ketanserine dose 0.353 0.058 <.001
Guardian 758.090
Peripheral temperature 0.006 0.003 .036 0.006 0.003 .048
Dopamine dose 0.007 0.003 .046 0.004 0.004 .336
Linear mixed-effects model for repeated measures, with the different patients as subjects and the 2-hour reference glucose measurements as repeated measures, using the
autoregressive (1) repeated covariance structure. Sensor accuracy (ie, relative absolute deviation) was the dependent variable. The covariates were put into the model as fixed
effects. AIC reflects model fit. Individual associations of variables with sensor accuracy (univariate) and basic model of both sensors including the variables with individual
significant association with sensor accuracy (multivariate). SE, Standard error; AIC, Akaike’s information criterion; APACHE IV PM, acute physiology and chronic health
evaluation IV predicted mortality; DM, diabetes mellitus.
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Mand StO2 was 2.8 (IQR, 2.7-2.9), 9.3 vessels/mm (IQR,
8.4-10.0), 0.97 (IQR, 0.96-0.99), 0.17 (IQR, 0.13-0.21),
and 90.3% (IQR, 87.1%-92.0%), respectively (Table 1).
The microcirculation variables were not different between
patients with and without diabetes. The mean  standard
deviation StO2 increased significantly during the first hours
of ICU admission, from 88.6% (5.6) to a maximum of
91.2% (3.9) after 6 hours, and decreased thereafter, stabiliz-
ing after 20 hours (Figure 2). This increase in StO2 was
accompanied by a decrease in PVD (b ¼ 0.697, standard
error, 0.267, P ¼ .01, linear mixed-effects model for
repeated measures). In line with this observation, we found
that the PVDwas lowest in the first 8 hours after ICU admis-
sion compared with the next day (median, 9.2; IQR, 8.1-9.9;
and median, 9.4; IQR, 8.6-10.5, respectively; P ¼ .049,
Wilcoxon signed ranks test). The MFI, PPV, and HI PVDFIGURE 1. Clarke error grid of glucose measurements. A, Navigator, and B, Gu
x-axis with proximate sensor values (within 10 minutes for the Navigator and
1286 The Journal of Thoracic and Cardiovascular Surdid not change over time. The arterial oxygen content
(hemoglobin concentration 3 pulse oximeter oxygen
saturation 3 1.34) was stable during ICU admission
(mean  standard deviation, 12.6  1.3 mL oxygen/100
mL). The MFI, PVD, and PPV were not influenced by
administration of vasopressor medication (dopamine,
norepinephrine, and enoximone). An increase in these
medications did increase the StO2 on univariate analysis.
However, the multivariate mixed-effects model analysis
showed no significant relationship. Also, the crossclamp
time during surgery was not related to the microcirculation
variables.
CGM Accuracy
Clarke error grids of reference glucose values with the
corresponding next sensor values are shown in Figure 1.ardian. Each grid shows the data pairs of the reference glucose values at the
5 minutes for the Guardian) at the y-axis.
gery c November 2013
FIGURE 2. Tissue oxygenation (StO2) in relation to arterial oxygen
content (CaO2) during intensive care unit (ICU) admission. Development
of mean  standard error StO2 (left y-axis) and CaO2 (right y-axis) during
ICU admission (x-axis).
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values, 81.8% of the Navigator and 73.2% of the available
Guardian glucose values were within zone A, and 17.7% of
the Navigator and 25.2% of the Guardian glucose values
were within zone B. Only 5 of the 934 Navigator values
were within zone C or D (0.5%), with none in zone
E, compared with 13 of the 790 Guardian values in zone
C, D, or E (1.3%). Overall, the Navigator sensor performed
significantly better than the Guardian sensor (median RAD,
11%; IQR, 8-16; vs median, 14%; IQR, 11-18; P ¼ .05).3
The variables that were individually associated with
worse Navigator sensor accuracy were older age, a
diagnosis of diabetes, a decreased peripheral temperature,
an increase in the ketanserin, dopamine, or enoximone
dose, and higher APACHE IV PM. Only a decreased
peripheral temperature and increasing dopamine use were
associated with decreased accuracy of the Guardian sensor
(Table 2). None of the microcirculation variables (Table 3;
an additional explanation of the microcirculation variablesTABLE 3. Forced introduction of microcirculatory variables
Variable B SE P value
Navigator
MFIs 0.021 0.041 .61
PVD 0.003 0.007 .63
PPV 0.147 0.307 .63
StO2 0.002 0.001 .12
Guardian
MFIs 0.101 0.063 .11
PVD 0.009 0.009 .33
PPV 0.256 0.448 .57
StO2 0.001 0.001 .61
The forced introduction of the microcirculatory variables in turn did not show a
significant association with sensor accuracy. SE, Standard error;MFIs,microvascular
flow index of small vessels; PVD, perfused vascular density; PPV, proportion of
perfused vessels; StO2, tissue oxygen saturation.
The Journal of Thoracic and Caris provided below) nor gender, mean arterial pressure,
norepinephrine dose, or nitroglycerine dose showed
significant associations with the accuracy of either of the
sensors.
Subsequently, we built a multivariate model per sensor
that included the significantly associated factors (Table 2).
Owing to collinearity between the APACHE IV PM and
the ketanserin dose, we only included APACHE IV PM in
the final model. This model showed that for the Navigator
only a higher APACHE IV PM, lower peripheral tempera-
ture, and older age remained significantly associated with
an increase in sensor RAD (ie, worse sensor accuracy).
For the Guardian, a decrease in the peripheral temperature
remained associated with an increase in the RAD.
Figure 3 shows the crude accuracy of both sensors stratified
by the peripheral temperature. Successively forcing these
variables in turn into the model did not reveal a significant
association with sensor accuracy (Table 3). It was not
possible to completely eliminate the glucose values in the
C, D, and E zones using various cutoff values for tempera-
ture, age, and APACHE IV PM score.
DISCUSSION
In the present study, we found acceptable continuous
glucose sensor accuracy and microcirculatory impairment
to a limited extent in cardiac surgery patients in the first
hours of ICU admission after surgery during a median
follow-up of 23 hours. Microcirculatory impairment was
reflected by a decrease in PVD and a transient increase in
StO2 but no differences in PPVand MFI. The microcircula-
tory variables showed no relationship with continuous
glucose sensor accuracy. The variables associated with
worse sensor accuracy were older age, lower peripheral
temperature, and higher APACHE IV PM for the NavigatorFIGURE3. Sensor accuracy in relation to peripheral temperature. Median
(interquartile range) relative absolute deviation (RAD) of both sensors
stratified by peripheral temperature quartile. The highest RAD was seen
at<31C and the lowest RAD at>34.11C. *P<.05.
diovascular Surgery c Volume 146, Number 5 1287
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Msensor and lower peripheral temperature for the Guardian
sensor.
Our results of the accuracy of the Guardian sensor are
comparable to those from Logtenberg et al,5 who also
performed a study of cardiac patients in the ICU and
reported a median RAD of 12.3% during the ICU period.
No studies using the Navigator in the ICU have been
published to date. Compared with the data from patients
with type 1 diabetes, the accuracy of both devices in our
ICU population was comparable for the Guardian18 and
even somewhat better for the Navigator.19 This suggests
that at least in the population of cardiac surgery patients,
CGM use is feasible.
A decrease in the peripheral temperature did influence
the accuracy of both sensors negatively. This finding was
in contrast to that of 1 other study performed in pediatric
cardiac surgery patients using the older Guardian RT
CGM system, which did not show a relationship.20 It is,
however, plausible that the temperature of the skin influ-
ences the sensor accuracy, because the optimal reaction
temperature for the glucose oxidase enzyme incorporated
in the sensors is 30C to 40C, and the skin temperature
during and shortly after cardiac surgery is often less than
that lower limit. Nevertheless, the decreased sensor
accuracy needs to be put into clinical perspective, because
the median and IQR RAD of both sensors during peripheral
temperatures <31C is still relatively low (Navigator,
10.5%, 4.8%-20.0%; Guardian, 14.7%, 6.6%-27.7%;
Figure 2).
The performance of the Navigator was also negatively
influenced by older age and higher APACHE IV PM. As
we hypothesized, the highest RAD was found in the more
severely ill patients because of more out-of-range glucose
values; however, apparently the microcirculatory variables
used did not mediate this effect in those with the highest
APACHE IV PM. The APACHE IV PM in our patient group
was relatively low; therefore, these results should not be
extrapolated to patients with higher severity of disease
scores. Age contributes to the APACHE IV PM and also
might be associated with skin-related factors influencing
sensor performance (eg, altered subcutaneous fat deposition
or vascularization). Notably, the accuracy of the Navigator
was influenced by more variables than was the accuracy of
the Guardian. Possibly, the inaccuracy of the Guardian was
largely dependent on sensor-related factors overruling the
influence of the patient-related variables.
Previous studies of microcirculatory function in post-
operative cardiac surgery patients have shown varying
results. Some have found normal MFI values at ICU
arrival21 and normal PVD values 1 hour after cardiopulmo-
nary bypass.22 In contrast, De Backer et al23 found a
decrease in PPV at the end of on-pump surgery that
persisted until 24 hours after surgery. Of note, other than
the present study, the latter study is the only study with1288 The Journal of Thoracic and Cardiovascular Sur>1 hour of follow-up during postoperative ICU admission
of cardiac surgery patients. The MFI, PPV, and HI found
in our population were roughly comparable to those of
healthy controls, as measured by Trzeciak et al.15 The
PVD in our group was somewhat smaller than in their
control group and not as low as in patients with sepsis.7
However, we did not have the opportunity to measure the
microcirculatory function preoperatively; therefore, we
were unable to assess the pre- to postoperative changes.
We found an increase in StO2 after ICU admission, with a
peak after 6 to 12 hours (Figure 2) and a gradual decrease
thereafter, stabilizing to normal levels<90% after 20 hours
of ICU stay. No studies measuring StO2 in patients after
cardiac surgery are known to us. Together with the increase
in StO2, the lowest PVD values were found in the first 8
hours of ICU admission, and the increase in StO2
was significantly associated with the decrease in PVD.
Endotoxin release and subsequent triggering of the inflam-
matory response observed during on-pump surgery could
explain these findings. Endotoxin levels peak shortly after
surgery, and the inflammatory response, represented by
the plasma interleukin-6 concentration, is found to be
highest after 6 hours,24 comparable to the observed peak
in StO2. A much larger inflammatory response will be
seen with sepsis and is accompanied by large microcircula-
tory changes7 and also a possible increase in StO2 owing to
impaired oxygen offloading in a hyperdynamic flow state.25
The changes seen in our population could thus have been
due to changes similar to, but much smaller than, those
seen in sepsis caused by distributive shock, owing to
arteriovenous shunting of the microcirculation reducing
the number of perfused vessels and thereby disabling
oxygen offloading. This hypothesis is supported by the
stable arterial oxygen content during ICU admission
(Figure 2), which makes it unlikely that the increased
StO2 could be explained by an increase in the oxygen
supply. One limitation of the present study was that we
were not able to investigate the relation between the
microcirculation parameters and the cardiac output as a
measure of the hemodynamic situation. This was because
in our unit almost no patients will have Swan-Ganz
catheters inserted, and, therefore, measurement of the
cardiac output is seldom available.
The microcirculatory variables did not influence the
accuracy of either sensor. As far as we know, no previous
studies have assessed this relationship. Our findings suggest
that the microcirculatory status does not impair glucose
transport in cardiac surgery patients, at least not to the
extent that it has an effect on the subcutaneous sensor
performance. The patients included in the present study
had a relatively good microcirculation as measured using
the MFI, PPV, and PVD, although the differences between
patients were quite large (PVD ranged from 5.9 to 13.8
vessels/mm). It remains to be established whether ingery c November 2013
Siegelaar et al Perioperative Managementpatients with worse overall microcirculatory variables, the
sensor performance will be affected.
In conclusion, the present study has shown that the sensor
accuracy of both sensors was acceptable in cardiac surgery
patients. The microcirculation showed some impairment
after surgery, reflected by a transient increase in StO2 and
a decrease in PVD; however, overall, it was quite good
compared with that in patients with sepsis and healthy
controls. The impairment in the microcirculatory variables
was not related to sensor accuracy but the peripheral
temperature (both sensors) and age and APACHE IV PM
(Navigator) was. These results support CGM use in cardiac
surgery patients characterized by a low severity of illness.
Additional studies are needed to assess the influence of
microcirculatory changes on sensor accuracy in more
severely ill patients.
The sensors used were provided free of charge by Medtronic
Minimed and at a discounted rate by Abbott Diabetes Care.
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